Concepedia

Toshiyuki Ishiwata

TI

Statistics

Publications

128

Citations

6.7K

H-Index

49

Active since

1983

Affiliations

Nippon Medical School(Current)

Tokyo Metropolitan Geriatric Hospital

Tokyo Metropolitan Institute of Gerontology

University of California, Irvine

Nippon Veterinary and Life Science University

Toshiyuki Ishiwata is an author at Nippon Medical School specializing in medicine, cell biology, and pathology.

ORCID

Top concepts

Publications per year

1983–2023

128

Publications

128

The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.

Jörg Kleeff, Toshiyuki Ishiwata, Asli Kumbasar et al. · Journal of Clinical Investigation · 1998 · 364 citations · Full text

, , +17

Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.

Jun Itakura, Toshiyuki Ishiwata, Helmut Friess et al. · PubMed · 1997 · 271 citations

, , +20

The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer

Jörg Kleeff, Toshiyuki Ishiwata, Haruhisa Maruyama et al. · Oncogene · 1999 · 258 citations

, , +7

Vascular Endothelial Growth Factor Enhances Glomerular Capillary Repair and Accelerates Resolution of Experimentally Induced Glomerulonephritis

Yukinari Masuda, Akira Shimizu, Takahiro Mori et al. · American Journal Of Pathology · 2001 · 235 citations · Full text

, , +14

Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer

Jun Itakura, Toshiyuki Ishiwata, Ben Shen et al. · International Journal of Cancer · 2000 · 233 citations

1–5 of 128